RobertCyrilBollingerJr.MD
Infectious Disease • Baltimore, MDProfessor of Medicine, Johns Hopkins University School of Medicine
Dr. Bollinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Baltimore, MD 21287Phone+1 410-955-5000Fax+1 410-955-5001
Education & Training
University of MarylandResidency, Internal Medicine, 1984 - 1987
Geisel School of Medicine at DartmouthClass of 1984
Certifications & Licensure
MD State Medical License 1985 - 2026- American Board of Internal Medicine Internal Medicine
Clinical Trials
- HIV Incidence and Participation Retention in Pune, India Start of enrollment: 2002 Aug 01
- Daily Nevirapine to Prevent Mother to Infant Transmission of HIV Start of enrollment: 2002 Aug 01
- Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks.Frank Mulindwa, Jean-Marc Schwarz, Nele Brusselaers, Martin Nabwana, Robert Bollinger
BMC Infectious Diseases. 2024-07-29 - Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report.Frank Mulindwa, Barbara Castelnuovo, Nele Brusselaers, Robert Bollinger, George Yendewa
BMC Infectious Diseases. 2023-10-30 - 1 citationsDolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults.Frank Mulindwa, Barbara Castelnuovo, Nele Brusselaers, Martin Nabwana, Robert Bollinger
AIDS Research and Therapy. 2023-09-09
Journal Articles
- Inflammation and Micronutrient Biomarkers Predict Clinical HIV Treatment Failure and Incident Active TB in HIV-Infected Adults: A Case-Control StudyRobert C Bollinger, Richard D Semba, Amita Gupta, BioMed Central
Press Mentions
FDA Says Three Negative Rapid Tests Are Needed for Asymptomatic Covid -News ForestAugust 14th, 2022- FDA Says Three Negative Rapid Tests Needed for Asymptomatic Covid CasesAugust 13th, 2022
- States with High Vaccination Rates Can Still Experience COVID-19 Surges — Here’s WhyNovember 28th, 2021
- Join now to see all
Grant Support
- Byramee Jeejeebhoy Medical College (Bjmc), Pune, India: Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2009
- Prevention Of Maternal-To-Infant HIV Transmission/IndiaNational Institute Of Allergy And Infectious Diseases2006–2008
- HIV Prevention Trial Unit (Hptu)-Pune, IndiaNational Institute Of Allergy And Infectious Diseases2000–2006
- Prevention Of Maternal-To-Infant HIV Transmission /IndiaNational Institute Of Allergy And Infectious Diseases2005
- Prevention Maternal To Infant HIV Transmission In IndiaNational Institute Of Allergy And Infectious Diseases1999–2005
- Reliability/Reproducibility Of Measurement Of CTL Activity In HIVNational Center For Research Resources1998–2002
- Pathogenesis Of Acute Primary HIV Infection In IndiaNational Institute Of Allergy And Infectious Diseases1998–2001
- HIV Specific CTL Activity In Concordant/Discordant PairsNational Institute Of Allergy And Infectious Diseases1999–2000
- CTL Activity In HIV1 Infected Individuals In IndiaFogarty International Center1997–1999
- Epidemiology And Incidence Of HIV 1 And 2National Institute Of Allergy And Infectious Diseases1994
- Epidemiology And Incidence Of HIV-1 And -2National Institute Of Allergy And Infectious Diseases1992–1993
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/robert-bollinger
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
